XML 125 R96.htm IDEA: XBRL DOCUMENT v3.23.1
Share-based payments - Equity share option and valuation of grants (Details)
€ / shares in Units, € in Thousands
12 Months Ended
Dec. 31, 2022
$ / shares
Dec. 31, 2022
EUR (€)
Y
Dec. 31, 2021
Y
$ / shares
Dec. 31, 2019
Y
€ / shares
Options. | Mr. Modig and Mr. Sheldon        
Key assumptions used to derive other equity instruments value        
Exercise price (USD)     $ 9.92  
Share price at grant date (USD)     $ 10.01  
Expected volatility (%)     75.00%  
Risk-free rate (%)     1.70%  
Dividend yield (%)     0.00%  
Expected contractual life (years) | Y     10.0  
Weighted average fair value (USD)     $ 7.86  
Options. | Mr. Modig        
Key assumptions used to derive other equity instruments value        
Exercise price (USD)     14.00  
Share price at grant date (USD)     $ 10.01  
Expected volatility (%)     75.00%  
Risk-free rate (%)     1.70%  
Dividend yield (%)     0.00%  
Expected contractual life (years) | Y     10  
Weighted average fair value (USD)     $ 7.45  
Options. | Mr. Kim        
Key assumptions used to derive other equity instruments value        
Exercise price (USD)     11.60  
Share price at grant date (USD)     $ 10.80  
Expected volatility (%)     75.00%  
Risk-free rate (%)     1.70%  
Dividend yield (%)     0.00%  
Expected contractual life (years) | Y     9  
Weighted average fair value (USD)     $ 8.21  
Performance Based RSUs | Mrs. Stratton        
Key assumptions used to derive other equity instruments value        
Share price at grant date (USD) $ 4.42      
Expected volatility (%)   80.00%    
Risk-free rate (%)   1.10%    
Dividend yield (%)   0.00%    
Expected contractual life (years) | Y   10    
Performance Based RSUs | Mrs. Stratton | Minimum        
Key assumptions used to derive other equity instruments value        
Exercise price (USD) 12.00      
Weighted average fair value (USD) 1.60      
Performance Based RSUs | Mrs. Stratton | Maximum        
Key assumptions used to derive other equity instruments value        
Exercise price (USD) 15.00      
Weighted average fair value (USD) 2.10      
Performance Based RSUs | Mr. Coego Rios        
Key assumptions used to derive other equity instruments value        
Share price at grant date (USD) 2.70      
Expected volatility (%)   80.00%    
Risk-free rate (%)   2.20%    
Dividend yield (%)   0.00%    
Expected contractual life (years) | Y   10    
Performance Based RSUs | Mr. Coego Rios | Minimum        
Key assumptions used to derive other equity instruments value        
Exercise price (USD) 12.00      
Weighted average fair value (USD) 0.35      
Performance Based RSUs | Mr. Coego Rios | Maximum        
Key assumptions used to derive other equity instruments value        
Exercise price (USD) 15.00      
Weighted average fair value (USD) 0.50      
RSUs | Mrs. Stratton        
Key assumptions used to derive other equity instruments value        
Share price at grant date (USD) 4.42      
Expected volatility (%)   85.00%    
Risk-free rate (%)   1.10%    
Dividend yield (%)   0.00%    
Expected contractual life (years) | Y   10    
RSUs | Mrs. Stratton | Minimum        
Key assumptions used to derive other equity instruments value        
Exercise price (USD) 5      
Weighted average fair value (USD) 1.45      
RSUs | Mrs. Stratton | Maximum        
Key assumptions used to derive other equity instruments value        
Exercise price (USD) 15      
Weighted average fair value (USD) 1.71      
RSUs | Mr. Coego Rios        
Key assumptions used to derive other equity instruments value        
Share price at grant date (USD) 2.70      
Expected volatility (%)   80.00%    
Risk-free rate (%)   2.20%    
Dividend yield (%)   0.00%    
Expected contractual life (years) | Y   10    
RSUs | Mr. Coego Rios | Minimum        
Key assumptions used to derive other equity instruments value        
Exercise price (USD) 5      
Weighted average fair value (USD) 0.84      
RSUs | Mr. Coego Rios | Maximum        
Key assumptions used to derive other equity instruments value        
Exercise price (USD) 15      
Weighted average fair value (USD) 0.65      
Equity share option 2017 (Equity settled)        
Key assumptions used to derive the option value        
Exercise price | € / shares       € 0.12
Share price at grant date | € / shares       € 12.58
Volatility (%)       70.00%
Risk-free interest rate (%)       (0.70%)
Dividend yield (%)       0.00%
Option term (years) | Y       10
Equity share option 2019 (Equity settled)        
Key assumptions used to derive the option value        
Exercise price | € / shares       € 12.58
Share price at grant date | € / shares       € 12.58
Volatility (%)       70.00%
Risk-free interest rate (%)       (0.70%)
Dividend yield (%)       0.00%
Option term (years) | Y       10
2019 Plan | Options.        
Key assumptions used to derive other equity instruments value        
Exercise price (USD)     12.52  
Share price at grant date (USD)     $ 12.54  
Expected volatility (%)     75.00%  
Risk-free rate (%)     1.90%  
Dividend yield (%)     0.00%  
Expected contractual life (years) | Y     10  
Weighted average fair value (USD)     $ 7.36  
2019 Plan | RSUs        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Amount of dividend payment expected over an vesting period | €   € 0    
Key assumptions used to derive other equity instruments value        
Weighted average fair value (USD) $ 1.93   $ 10.96